8-K - Hepion Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On February 25, 2026, Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), entered into an intell

Material Agreement

8.01

Other Events. On March 3, 2026, the Company issued a press release (the “Press Release”) announcing it has in-licensed from Cirna a novel biomarker assay that d

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release dated March 3, 2026 104 Cover Page Interactive Data File (embedded within the XBRL document)

Exhibits Only

Exhibits (2)

8-K

99.1

EX-99.1